Loading…
Loading grant details…
| Funder | NATIONAL HEART, LUNG, AND BLOOD INSTITUTE |
|---|---|
| Recipient Organization | Cincinnati Childrens Hosp Med Ctr |
| Country | United States |
| Start Date | Sep 01, 2024 |
| End Date | Aug 31, 2029 |
| Duration | 1,825 days |
| Number of Grantees | 3 |
| Roles | Co-Investigator; Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10974509 |
ABSTRACT/SUMMARY Leveraging the technologies and infrastructure in our previous LungMAP phases, we will construct a multi-scale map of developing acinar and alveolar structures during normal childhood and in the setting of childhood interstitial lung disease (chILD) characterized by aberrant lung morphogenesis. Linked to gene variants, chILD
provides a unique opportunity to understand key genetic pathways and cellular interactions of human acinar and alveolar development, in turn informing injury-repair associated with lung diseases throughout the lifespan. Working in a collaborative LungMAP3 consortium, including other Research Centers, the Data Coordinating
Center (DCC), the Human Tissue Core (HTC), our LungMAP3 project will use single-cell and spatial multiomics, high-resolution confocal and electron microscopy, patient-derived iPSCs, and bioinformatics including AI tools to define, model, and predict normal and diseased lung development. The resulting mechanistic insights and
enabling technologies will be disseminated to the entire lung community via disease atlases and web portals, as we have done during LungMAP1 and 2, to accelerate lung biology discoveries and disease therapies.
Cincinnati Childrens Hosp Med Ctr
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant